Cancer doesn’t take a break, not even for a worldwide pandemic. The newly established Cancer Center at Brown University, directed by Dr. Wafik El-Deiry, is making sure advances in research and improvements to patient care continue uninterrupted.
In “Decoding Disparities,” presented by Brown’s Warren Alpert Medical School and School of Public Health, experts will discuss adverse impacts on the health of Black and Indigenous individuals and people of color in America.
Pediatric neuro-oncologist Stephen Gilheeney ’95 MMSc’97 MD’99 works with children and families affected by brain and spinal cord tumors. Although COVID-19 has changed the way he practices, he credits his experience at Brown—both as an undergraduate and in the Warren Alpert Medical School—with helping him become an exceptional physician.
Several faculty members across disciplines have shifted their research and community engagement efforts to focus specifically on COVID-19. Through their expertise and collaboration, they're providing a guide for addressing both the immediate and future effects of this global health and economic crisis.
By 2040, approximately one in five people in the U.S. will be 65 years old or older. As Americans are increasingly dealing with age-related diseases such as diabetes, heart disease, stroke, and Alzheimer’s, Brown researchers are trying to understand why aging occurs in an attempt to meet the country’s growing health care needs.
By recruiting and supporting more aspiring physicians from underrepresented groups, like Krissia Rivera Perla ’15 MD’21, the Warren Alpert Medical School is increasing diversity at Brown and shaping the future of effective patient care.
As a practicing emergency physician, Dr. Megan Ranney MPH’10 RES’08 believes that the emergency department is where you can change a patient’s health care trajectory. And technology is her tool of choice.
By bringing together Brown’s Warren Alpert Medical School and six medical practices employing more than 500 doctors, BPI will enable a new level of coordination for research, teaching and clinical care in southern New England.
Brown’s new Biomedical Innovation Fund has made two grants to accelerate the commercialization of technologies — one for diagnosing drug dependence in newborns and a second for discovering anti-ALS medicines.
A new gift from The Warren Alpert Foundation will allow the University to substantially expand and enhance its M.D./Ph.D. program and endow a professorship in the Brown Institute for Translational Science.